FDA approves Verily’s Study Watch to monitor cardiovascular conditions
Verily Life Sciences has received a new clearance from the Food and Drug Administration allowing the use of its Study Watch to monitor patients with cardiovascular conditions.
More for you
See AllLoading data for hdm_tax_topic #better-outcomes...